<scp>COVID</scp>‐19, neuroleptic malignant syndrome and psychosis

نویسندگان

چکیده

Neuroleptic malignant syndrome (NMS) can be a severe condition requiring emergency treatment. Misdiagnosis or delay in treatment prove fatal. An unusual presentation of NMS is outlined patient being restarted on clozapine following mild COVID‐19 infection. A discussion explores its pathogenicity and the various ways it present clinically, which further illustrates atypical features this case.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Olanzapine-Induced Neuroleptic Malignant Syndrome

Neuroleptic malignant syndrome (NMS) is a rare but life-threatening idiosyncratic side effect resulting from neuroleptic drugs. NMS mainly occurs in patients treated with high-potency typical antipsychotics, but rarely caused by atypical antipsychotics. Although NMS is less common with atypical antipsychotic, but it seems that its incidence is rising due to increased administration of such drug...

متن کامل

A diagnostic dilemma between psychosis, neuroleptic malignant syndrome and encephalitis

We describe the case of a patient presenting with symptoms highly suggestive of a psychotic illness. Prior to an organic assessment, antipsychotics were commenced at an early stage, causing neuroleptic malignant syndrome and contributing to confusion regarding the pathophysiology and etiology of the presentation. The chronology of symptoms was suggestive of a disease process prior to neurolepti...

متن کامل

Neuroleptic malignant syndrome.

The neuroleptic malignant syndrome is an uncommon, severe illness that consists of fever, muscular rigidity, and stupor. Various neuroleptics have been associated with the disease. A detailed neurological, medical, and neuropathological evaluation of this case was performed. Presumably, the syndrome is secondary to biochemical dysfunction of the basal ganglia and possible of the hypothalmus.

متن کامل

Neuroleptic malignant syndrome.

We present the case of a 35-year-old man who developed symptoms of the neuroleptic malignant syndrome (NMS) after taking prescribed, moderately high, therapeutic doses of haloperidol. When brought to the emergency department, he was comatose, hypotensive, and had rigid muscle tone and a core body temperature of 42.2 C. Although initial treatment was supportive, intubation, ventilator support, a...

متن کامل

Neuroleptic malignant syndrome.

Neuroleptic malignant syndrome is a rare, idiosyncratic condition related to neuroleptic use which may develop at any stage during neuroleptic treatment and can prove fatal. Although most commonly seen in psychiatric patients, anyone prescribed a neuroleptic is at risk and it has been associated with other agents. This article discusses its recognition, risk factors, clinical course and treatme...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Progress in Neurology and Psychiatry

سال: 2021

ISSN: ['1931-227X', '1367-7543']

DOI: https://doi.org/10.1002/pnp.713